Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.17M | 10.86M | 9.37M | 5.86M | 5.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.46M | 14.73M | 14.69M | 12.56M | 12.89M |
| Operating Income | -10.46M | -14.73M | -14.69M | -12.56M | -12.89M |
| Income Before Tax | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M |
| EBIT | -10.46M | -14.73M | -14.69M | -12.56M | -12.89M |
| EBITDA | -10.41M | -14.67M | -14.64M | -12.51M | -12.83M |
| EPS Basic | -0.19 | -0.28 | -0.28 | -0.37 | -0.37 |
| Normalized Basic EPS | -0.12 | -0.17 | -0.18 | -0.23 | -0.23 |
| EPS Diluted | -0.19 | -0.28 | -0.28 | -0.37 | -0.37 |
| Normalized Diluted EPS | -0.12 | -0.17 | -0.18 | -0.23 | -0.23 |
| Average Basic Shares Outstanding | 53.38M | 53.28M | 51.02M | 34.69M | 34.69M |
| Average Diluted Shares Outstanding | 53.38M | 53.28M | 51.02M | 34.69M | 34.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |